IGC Pharma, Inc.
IGC
$0.3262
$0.01986.46%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 37.72% | -16.33% | -23.22% | -12.98% | -1.19% |
| Total Depreciation and Amortization | 0.32% | -1.10% | -0.92% | -3.04% | -6.43% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -69.00% | 154.90% | 156.60% | 75.20% | 27.85% |
| Change in Net Operating Assets | 1.44% | -0.11% | 4.21% | 138.54% | -28.70% |
| Cash from Operations | 25.83% | 22.24% | 13.23% | 26.22% | 3.54% |
| Capital Expenditure | 14.84% | 58.90% | 23.15% | 55.48% | 67.10% |
| Sale of Property, Plant, and Equipment | -50.00% | -94.06% | -99.83% | -91.82% | -93.72% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -269.44% | -244.62% | 37.39% | 51.84% | 80.27% |
| Cash from Investing | -163.98% | -202.08% | -440.24% | -34.89% | 56.78% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 25.00% | 0.00% | 0.00% | 0.00% | -33.33% |
| Issuance of Common Stock | 50.91% | 38.81% | 5,759.22% | 3,324.27% | 2,676.70% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 51.02% | 38.85% | 5,932.00% | 3,424.00% | 2,756.00% |
| Foreign Exchange rate Adjustments | -333.33% | 45.45% | 82.76% | 92.68% | 102.26% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 74.54% | 58.85% | 101.60% | 72.49% | 49.01% |
